[go: up one dir, main page]

GB9226283D0 - Vaccines - Google Patents

Vaccines

Info

Publication number
GB9226283D0
GB9226283D0 GB929226283A GB9226283A GB9226283D0 GB 9226283 D0 GB9226283 D0 GB 9226283D0 GB 929226283 A GB929226283 A GB 929226283A GB 9226283 A GB9226283 A GB 9226283A GB 9226283 D0 GB9226283 D0 GB 9226283D0
Authority
GB
United Kingdom
Prior art keywords
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929226283A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GB929226283A priority Critical patent/GB9226283D0/en
Publication of GB9226283D0 publication Critical patent/GB9226283D0/en
Priority to PL93306722A priority patent/PL170980B1/en
Priority to HK98110943.0A priority patent/HK1010097B/en
Priority to SG1996009012A priority patent/SG49909A1/en
Priority to DE69313134T priority patent/DE69313134T2/en
Priority to UA95018058A priority patent/UA40597C2/en
Priority to CZ943296A priority patent/CZ282235B6/en
Priority to PCT/EP1993/001524 priority patent/WO1994000153A1/en
Priority to SK1592-94A priority patent/SK279188B6/en
Priority to DK93912990.4T priority patent/DK0671948T3/en
Priority to ES96203085T priority patent/ES2143716T3/en
Priority to CA002138997A priority patent/CA2138997C/en
Priority to RU94046232A priority patent/RU2118164C1/en
Priority to KR1019940704740A priority patent/KR100278157B1/en
Priority to NZ253137A priority patent/NZ253137A/en
Priority to PT96203085T priority patent/PT761231E/en
Priority to EP93912990A priority patent/EP0671948B1/en
Priority to US08/356,372 priority patent/US5750110A/en
Priority to HU9403778A priority patent/HU219808B/en
Priority to EP96203085A priority patent/EP0761231B1/en
Priority to DK96203085T priority patent/DK0761231T3/en
Priority to ES93912990T priority patent/ES2108278T3/en
Priority to JP50200594A priority patent/JP3755890B2/en
Priority to AT96203085T priority patent/ATE188613T1/en
Priority to AT93912990T priority patent/ATE156710T1/en
Priority to SG9901248A priority patent/SG90042A1/en
Priority to AU43263/93A priority patent/AU661404B2/en
Priority to DE69327599T priority patent/DE69327599T2/en
Priority to MYPI93001207A priority patent/MY109278A/en
Priority to MA23212A priority patent/MA22911A1/en
Priority to IL10610993A priority patent/IL106109A/en
Priority to SI9300335A priority patent/SI9300335B/en
Priority to MX9303773A priority patent/MX9303773A/en
Priority to APAP/P/1993/000541A priority patent/AP408A/en
Priority to CN93107990A priority patent/CN1122530C/en
Priority to SA93140234A priority patent/SA93140234B1/en
Priority to NO19945003A priority patent/NO317546B1/en
Priority to FI946064A priority patent/FI109767B/en
Priority to US08/909,879 priority patent/US7147862B1/en
Priority to GR970402819T priority patent/GR3025184T3/en
Priority to HK99105834.1A priority patent/HK1022074B/en
Priority to GR20000400442T priority patent/GR3032742T3/en
Pending legal-status Critical Current

Links

GB929226283A 1992-06-25 1992-12-17 Vaccines Pending GB9226283D0 (en)

Priority Applications (42)

Application Number Priority Date Filing Date Title
GB929226283A GB9226283D0 (en) 1992-12-17 1992-12-17 Vaccines
DE69327599T DE69327599T2 (en) 1992-06-25 1993-06-15 Vaccine composition containing adjuvants
DK96203085T DK0761231T3 (en) 1992-06-25 1993-06-15 Vaccine containing adjuvants
ES93912990T ES2108278T3 (en) 1992-06-25 1993-06-15 COMPOSITION OF VACCINE WITH ADJUSTMENTS.
AT96203085T ATE188613T1 (en) 1992-06-25 1993-06-15 VACCINE COMPOSITION CONTAINING ADJUVANTS
DE69313134T DE69313134T2 (en) 1992-06-25 1993-06-15 VACCINE COMPOSITION CONTAINING ADJUVANTIES
UA95018058A UA40597C2 (en) 1992-06-25 1993-06-15 Vaccine composition, method for treatment of mammals, diseased or receptive to the infection, method for treatment of mammals with cancer, method for production of vaccine composition, composition of adjuvants
CZ943296A CZ282235B6 (en) 1992-06-25 1993-06-15 Inoculation substance, process of its preparation and use
PCT/EP1993/001524 WO1994000153A1 (en) 1992-06-25 1993-06-15 Vaccine composition containing adjuvants
SK1592-94A SK279188B6 (en) 1992-06-25 1993-06-15 A vaccine composition, a method of its preparation and its use
DK93912990.4T DK0671948T3 (en) 1992-06-25 1993-06-15 Vaccine containing adjuvants
ES96203085T ES2143716T3 (en) 1992-06-25 1993-06-15 VACCINE COMPOSITION CONTAINING ADJUVANTS.
CA002138997A CA2138997C (en) 1992-06-25 1993-06-15 Vaccine composition containing adjuvants
RU94046232A RU2118164C1 (en) 1992-06-25 1993-06-15 Vaccine composition showing property to cause cytolytic t-cellular response in mammals, method of preparing cytolytic t-cellular response in vitro, method of vaccine preparing
KR1019940704740A KR100278157B1 (en) 1992-06-25 1993-06-15 Vaccine Compositions Containing Supplements
NZ253137A NZ253137A (en) 1992-06-25 1993-06-15 Vaccine comprising antigen and/or antigenic composition, qs21 (quillaja saponaria molina extract) and 3 de-o-acylated monophosphoryl lipid a.
PT96203085T PT761231E (en) 1992-06-25 1993-06-15 COMPOSITION OF VACCINES CONTAINING ADJUVANTES
EP93912990A EP0671948B1 (en) 1992-06-25 1993-06-15 Vaccine composition containing adjuvants
US08/356,372 US5750110A (en) 1992-06-25 1993-06-15 Vaccine composition containing adjuvants
HU9403778A HU219808B (en) 1992-06-25 1993-06-15 Vaccine composition containing adjuvant and process for preparation thereof
EP96203085A EP0761231B1 (en) 1992-06-25 1993-06-15 Vaccine composition containing adjuvants
PL93306722A PL170980B1 (en) 1992-06-25 1993-06-15 Vaccine PL PL PL PL PL PL PL
JP50200594A JP3755890B2 (en) 1992-06-25 1993-06-15 Adjuvant-containing vaccine composition
HK98110943.0A HK1010097B (en) 1992-06-25 1993-06-15 Vaccine composition containing adjuvants
SG1996009012A SG49909A1 (en) 1992-06-25 1993-06-15 Vaccine composition containing adjuvants
AT93912990T ATE156710T1 (en) 1992-06-25 1993-06-15 VACCINE COMPOSITION CONTAINING ADJUVANTS
SG9901248A SG90042A1 (en) 1992-06-25 1993-06-15 Vaccine composition containing adjuvants
AU43263/93A AU661404B2 (en) 1992-06-25 1993-06-15 Vaccine composition containing adjuvants
MYPI93001207A MY109278A (en) 1992-06-25 1993-06-22 Vaccines
MX9303773A MX9303773A (en) 1992-06-25 1993-06-23 VACCINE COMPOSITION COMPRISING AN ANTIGEN AND / OR AN ANTIGENIC COMPOSITION OF QS21 AND MONOFOSFORIL-LIPIDO A 3-DES-O-ACILADO AND PROCESS FOR ITS ELABORATION.
MA23212A MA22911A1 (en) 1992-06-25 1993-06-23 PROCESS FOR PRODUCING VACCINE FORMULATIONS.
IL10610993A IL106109A (en) 1992-06-25 1993-06-23 Vaccine compositions comprising QS21 and 3D-MPL
SI9300335A SI9300335B (en) 1992-06-25 1993-06-23 Vaccine composition comprising 3-de-o-acylated monophosphorous lipid a and qs21
APAP/P/1993/000541A AP408A (en) 1992-06-25 1993-06-24 Vaccine composition containing adjuvants.
CN93107990A CN1122530C (en) 1992-06-25 1993-06-24 Vaccines
SA93140234A SA93140234B1 (en) 1992-06-25 1993-10-03 ADJUVANTS vaccine formulation containing immunostimulants
FI946064A FI109767B (en) 1992-06-25 1994-12-23 Procedure for manufacturing vaccine composition
NO19945003A NO317546B1 (en) 1992-06-25 1994-12-23 Vaccine admixture, and the use and method of preparation thereof
US08/909,879 US7147862B1 (en) 1992-06-25 1997-08-12 Vaccine composition containing adjuvants
GR970402819T GR3025184T3 (en) 1992-06-25 1997-10-29 Vaccine composition containing adjuvants.
HK99105834.1A HK1022074B (en) 1992-06-25 1998-09-24 Vaccine composition containing adjuvants
GR20000400442T GR3032742T3 (en) 1992-06-25 2000-02-23 Vaccine composition containing adjuvants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929226283A GB9226283D0 (en) 1992-12-17 1992-12-17 Vaccines

Publications (1)

Publication Number Publication Date
GB9226283D0 true GB9226283D0 (en) 1993-02-10

Family

ID=10726740

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929226283A Pending GB9226283D0 (en) 1992-06-25 1992-12-17 Vaccines

Country Status (1)

Country Link
GB (1) GB9226283D0 (en)

Similar Documents

Publication Publication Date Title
AP9300541A0 (en) Vaccines
AP9300530A0 (en) Vaccines
ZA947828B (en) Vaccines
IL99899A0 (en) Vaccines
GB9325496D0 (en) Vaccines
GB9215233D0 (en) Vaccines
GB9214871D0 (en) Vaccines
ZA93919B (en) Vaccines
GB9201023D0 (en) Vaccines
GB9213559D0 (en) Vaccines
ZA948685B (en) Vaccines
GB9322808D0 (en) Vaccines
GB9226768D0 (en) Vaccines
ZA933541B (en) Vaccines
GB9217635D0 (en) Vaccines
GB9216317D0 (en) Vaccines
GB9220360D0 (en) Vaccines
GB9221891D0 (en) Vaccines
ZA935281B (en) Vaccines
GB9226283D0 (en) Vaccines
GB9218833D0 (en) Vaccines
GB9211318D0 (en) Vaccines
GB9206786D0 (en) Vaccine
GB9307028D0 (en) Vaccine
GB9206789D0 (en) Vaccine